Anavex Life Sciences Corp. (AVXL) Ownership
AVXL ownership summary
as of October 18, 2026- Institutions
- 40.4% of shares outstanding
- Insiders
- 1.71% of shares outstanding
- Shares outstanding
- 92.7M
- Float
- 89.8M shares available to trade
- Short interest
- 14.89% 13.6M shares short
- Days to cover
- 16.63 short interest down 5.4% vs prior month
- Institutions 40.44%
- Insiders 1.71%
- Other investors 57.85%
AVXL top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.69% | 8.1M | $10.6M | +446,010 (+5.9%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 4.37% | 4.1M | $5.3M | +190,639 (+4.9%) | June 30, 2026 |
| 3 | Two Sigma Investments LLC | 3.29% | 3.0M | $4.0M | −201,350 (−6.2%) | June 30, 2026 |
| 4 | Geode Capital Management, LLC | 2.60% | 2.4M | $3.2M | +219,198 (+10.0%) | June 30, 2026 |
| 5 | State Street Corp | 2.07% | 1.9M | $2.5M | −2.6M (−57.4%) | June 30, 2026 |
| 6 | Federated Hermes Inc | 1.16% | 1.1M | $1.4M | +539,557 (+101.4%) | June 30, 2026 |
| 7 | AQR Capital Management LLC | 1.04% | 963K | $1.3M | +206,222 (+27.2%) | June 30, 2026 |
| 8 | Vanguard Portfolio Management, LLC | 1.02% | 949K | $1.2M | +165,485 (+21.1%) | June 30, 2026 |
| 9 | Summit Financial LLC | 0.98% | 909K | $1.2M | −31,025 (−3.3%) | June 30, 2026 |
| 10 | The Goldman Sachs Group Inc | 0.96% | 891K | $1.2M | +86,199 (+10.7%) | June 30, 2026 |
| 11 | Marshall Wace Asset Management Ltd | 0.96% | 890K | $1.2M | +470,026 (+112.0%) | June 30, 2026 |
| 12 | Northern Trust Corp | 0.85% | 784K | $1.0M | +59,307 (+8.2%) | June 30, 2026 |
| 13 | Barclays PLC | 0.81% | 754K | $988,036 | +215,949 (+40.1%) | June 30, 2026 |
| 14 | Charles Schwab Investment Management Inc | 0.79% | 735K | $962,581 | −21,763 (−2.9%) | June 30, 2026 |
| 15 | Bank of America Corp | 0.71% | 654K | $857,126 | −208,855 (−24.2%) | June 30, 2026 |
| 16 | Vanguard Fiduciary Trust Co | 0.67% | 621K | $814,101 | −25,718 (−4.0%) | June 30, 2026 |
| 17 | UBS Group AG | 0.67% | 620K | $812,690 | +50,418 (+8.8%) | June 30, 2026 |
| 18 | Private Advisor Group, LLC | 0.54% | 504K | $660,240 | +4,300 (+0.9%) | June 30, 2026 |
| 19 | LPL Financial Corp | 0.44% | 406K | $532,003 | −12,531 (−3.0%) | June 30, 2026 |
| 20 | Stifel Financial Corp | 0.36% | 333K | $435,702 | +95,793 (+40.5%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 2.7M shares and 7 cut 3.1M.
AVXL top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.16% | 2.9M | $3.8M | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 2.62% | 2.4M | $3.2M | −28,032 (−1.1%) | September 30, 2026 |
| 3 | Federated Hermes MDT Small Cap Core IS | 1.15% | 1.1M | $1.4M | +542,592 (+103.1%) | June 30, 2026 |
| 4 | Fidelity Small Cap Index | 1.08% | 1.0M | $1.3M | −1,235 (−0.1%) | July 31, 2026 |
| 5 | iShares Russell 2000 Value ETF | 0.80% | 741K | $970,490 | +1,124 (+0.2%) | September 30, 2026 |
| 6 | iShares Biotechnology ETF | 0.75% | 698K | $914,181 | −5,288 (−0.8%) | September 30, 2026 |
| 7 | Vanguard Russell 2000 ETF | 0.58% | 534K | $698,920 | +4,189 (+0.8%) | September 30, 2026 |
| 8 | Schwab US Small-Cap ETF™ | 0.53% | 490K | $641,652 | +324 (+0.1%) | September 30, 2026 |
| 9 | Fidelity Extended Market Index | 0.43% | 398K | $521,417 | +103,189 (+35.0%) | August 31, 2026 |
| 10 | iShares Micro-Cap ETF | 0.31% | 291K | $381,310 | −2,007 (−0.7%) | September 30, 2026 |
| 11 | Vanguard Health Care ETF | 0.29% | 271K | $354,647 | +300 (+0.1%) | September 30, 2026 |
| 12 | Schwab Small Cap Index | 0.24% | 225K | $294,576 | — | August 31, 2026 |
| 13 | Stt Strt SPDR® Russell2000 US SmCapETF | 0.22% | 206K | $270,294 | −14,360 (−6.5%) | September 30, 2026 |
| 14 | iShares Russell 2000 Growth ETF | 0.22% | 204K | $267,843 | −259 (−0.1%) | September 30, 2026 |
| 15 | iShares Russell 2000 Small-Cap Idx Instl | 0.20% | 187K | $244,527 | — | August 31, 2026 |
| 16 | Fidelity Total Market Index | 0.19% | 176K | $230,356 | — | August 31, 2026 |
| 17 | iShares U.S. Small-Cap Eq Fac ETF | 0.19% | 172K | $224,985 | — | September 30, 2026 |
| 18 | Fidelity Series Total Market Index | 0.15% | 140K | $183,561 | — | August 31, 2026 |
| 19 | iShares Core S&P Total US Stock Mkt ETF | 0.13% | 124K | $162,752 | +110 (+0.1%) | September 30, 2026 |
| 20 | Nuveen Small Cap Blend Idx R6 | 0.13% | 122K | $159,904 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
AVXL insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-14 | Peter D.O. Donhauser | Buy | $3.64 | 2,835 | $10,319 |
| 2024-05-15 | Steffen Thomas | Buy | $4.52 | 5,000 | $22,600 |
| 2024-03-28 | Christopher U Missling | Sell | $5.11 | 73,380 | $374,972 |
| 2023-06-28 | Christopher U Missling | Sell | $7.98 | 268,000 | $2.1M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
AVXL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns AVXL
Institutional investors own 40.4% of Anavex Life Sciences's shares and insiders 1.71%. The largest holder is BlackRock Inc with 8.69% of the shares (8.1M), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 7 reduced their stake in the latest filings. Short interest is 14.89% of the float, or 16.63 days of average trading volume. The share count rose 589.7% since 2014.
Related: AVXL analyst forecast, AVXL key metrics. See the AVXL stock overview for the latest quote and news.
AVXL ownership FAQ
Who owns the most Anavex Life Sciences stock?
The largest shareholders of Anavex Life Sciences are BlackRock Inc (8.69%), Vanguard Capital Management, LLC (4.37%), Two Sigma Investments LLC (3.29%), Geode Capital Management, LLC (2.60%), State Street Corp (2.07%).
What percentage of Anavex Life Sciences is owned by institutions?
Institutions hold 40.4% of Anavex Life Sciences's shares outstanding; insiders hold 1.71%.
Which funds own Anavex Life Sciences?
The largest fund holders of Anavex Life Sciences are Vanguard MStar Total Stk Mkt Idx Invest (3.16%), iShares Russell 2000 ETF (2.62%), Federated Hermes MDT Small Cap Core IS (1.15%), Fidelity Small Cap Index (1.08%), iShares Russell 2000 Value ETF (0.80%).
What is Anavex Life Sciences's short interest?
13.6M shares of Anavex Life Sciences were sold short, 14.89% of the float; at the average daily volume it would take 16.63 days to cover.
Are insiders buying or selling Anavex Life Sciences?
Of the latest 4 reported insider transactions in Anavex Life Sciences (since June 28, 2023), 2 were purchases and 2 were sales.
How many shares of Anavex Life Sciences are outstanding?
Anavex Life Sciences has 92.7M shares outstanding, of which 89.8M are in the public float.